GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » Median PS Value

Cordlife Group (SGX:P8A) Median PS Value : S$0.46 (As of Dec. 15, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cordlife Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was S$0.143. Cordlife Group's 10-Year median PS Ratio is 3.2168. Therefore, the Median PS Value for today is S$0.46.

As of today (2024-12-15), Cordlife Group's share price is S$0.156. Cordlife Group's Median PS Value is S$0.46. Therefore, Cordlife Group's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Cordlife Group's Median PS Value or its related term are showing as below:

During the past 12 years, the highest Price to Median PS Value of Cordlife Group was 0.68. The lowest was 0.44. And the median was 0.52.

SGX:P8A's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.91
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Cordlife Group Median PS Value Historical Data

The historical data trend for Cordlife Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group Median PS Value Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.77 0.72 0.46

Cordlife Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.72 - 0.46 -

Competitive Comparison of Cordlife Group's Median PS Value

For the Diagnostics & Research subindustry, Cordlife Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Price-to-Median-PS-Value falls into.



Cordlife Group Median PS Value Calculation

Cordlife Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.143*3.2168
=0.46

10-Year Median PS Ratio is 3.2168.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cordlife Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was S$0.143.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group  (SGX:P8A) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Cordlife Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.156/0.46
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group Median PS Value Related Terms

Thank you for viewing the detailed overview of Cordlife Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group Business Description

Traded in Other Exchanges
N/A
Address
1 Yishun Industrial Street 1, Number 06-01/09, A\'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, which comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group Headlines

No Headlines